Edwards Lifesciences Shares Outstanding 2006-2019 | EW

Edwards Lifesciences shares outstanding history from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Edwards Lifesciences shares outstanding for the quarter ending March 31, 2019 were 0.212B, a 1.35% decline year-over-year.
  • Edwards Lifesciences 2018 shares outstanding were 0.214B, a 1.07% decline from 2017.
  • Edwards Lifesciences 2017 shares outstanding were 0.216B, a 0.87% decline from 2016.
  • Edwards Lifesciences 2016 shares outstanding were 0.218B, a 1.13% decline from 2015.
Edwards Lifesciences Annual Shares Outstanding
(Millions of Shares)
2018 214
2017 216
2016 218
2015 220
2014 217
2013 228
2012 237
2011 239
2010 238
2009 235
2008 238
2007 251
2006 256
2005 249
Edwards Lifesciences Quarterly Shares Outstanding
(Millions of Shares)
Q1 2019 212
Q4 2018 214
Q3 2018 213
Q2 2018 214
Q1 2018 215
Q4 2017 216
Q3 2017 216
Q2 2017 216
Q1 2017 216
Q4 2016 218
Q3 2016 218
Q2 2016 217
Q1 2016 218
Q4 2015 220
Q3 2015 220
Q2 2015 220
Q1 2015 221
Q4 2014 217
Q3 2014 217
Q2 2014 215
Q1 2014 217
Q4 2013 228
Q3 2013 226
Q2 2013 229
Q1 2013 233
Q4 2012 237
Q3 2012 238
Q2 2012 237
Q1 2012 236
Q4 2011 239
Q3 2011 238
Q2 2011 240
Q1 2011 241
Q4 2010 238
Q3 2010 238
Q2 2010 238
Q1 2010 238
Q4 2009 235
Q3 2009 235
Q2 2009 234
Q1 2009 234
Q4 2008 238
Q3 2008 236
Q2 2008 241
Q1 2008 234
Q4 2007 251
Q3 2007 250
Q2 2007 252
Q1 2007 254
Q4 2006 256
Q3 2006 254
Q2 2006 257
Q1 2006 258
Q4 2005 249
Q3 2005 239
Q2 2005 250
Q1 2005 260
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $39.801B $3.723B
Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards Lifesciences Corporation is headquartered in Irvine, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $115.527B 25.27
Intuitive Surgical (ISRG) United States $60.928B 56.14
IDEXX Laboratories (IDXX) United States $24.444B 64.13
Fresenius Medical Care AG KGaA (FMS) Germany $24.394B 16.03
Teleflex (TFX) United States $15.460B 33.50
Olympus (OCPNY) Japan $15.407B 115.28
SONOVA HOLDING (SONVY) Switzerland $14.561B 0.00
Sysmex ADR (SSMXY) Japan $14.417B 38.87
DexCom (DXCM) United States $13.759B 269.84
Hologic (HOLX) United States $12.689B 20.41
STERIS (STE) Ireland $12.575B 30.42
Varian Medical Systems (VAR) United States $12.300B 31.38
ABIOMED (ABMD) United States $11.800B 71.79
Masimo (MASI) United States $8.237B 50.47
Penumbra (PEN) United States $6.000B 254.01
SARTORIUS AG (SARTF) Germany $5.850B 53.60
Elekta AB (EKTAY) Sweden $5.153B 38.83
Integra LifeSciences Holdings (IART) United States $4.599B 21.61
Globus Medical (GMED) United States $4.096B 25.54
Tandem Diabetes Care (TNDM) United States $3.740B 0.00
LivaNova (LIVN) United Kingdom $3.605B 23.50
Wright Medical Group (WMGI) Netherlands $3.365B 667.00
Cantel Medical (CMD) United States $3.364B 34.13
Glaukos (GKOS) United States $2.750B 0.00
Integer Holdings (ITGR) United States $2.675B 19.71
Nihon Kohden (NHNKY) Japan $2.449B 24.64
AVANOS MEDICAL, INC (AVNS) United States $2.029B 32.12
Nevro (NVRO) United States $1.983B 0.00
Inogen (INGN) United States $1.373B 30.40
OPKO Health (OPK) United States $1.317B 0.00
Silk Road Medical (SILK) United States $1.239B 0.00
Veracyte (VCYT) United States $1.167B 0.00
CryoLife (CRY) United States $1.116B 110.70
Accelerate Diagnostics (AXDX) United States $1.055B 0.00
Tactile Systems Technology (TCMD) United States $1.032B 152.33
ORTHOFIX MEDICAL INC (OFIX) United States $0.983B 28.48
Mesa Laboratories (MLAB) United States $0.912B 42.88
Pacific Biosciences Of California (PACB) United States $0.910B 0.00
ViewRay (VRAY) United States $0.907B 0.00
Luminex (LMNX) United States $0.882B 115.35
Natus Medical (BABY) United States $0.880B 20.37
AngioDynamics (ANGO) United States $0.810B 26.55
AxoGen (AXGN) United States $0.767B 0.00
Fluidigm (FLDM) United States $0.759B 0.00
Quotient (QTNT) Switzerland $0.696B 0.00
Intersect ENT (XENT) United States $0.651B 0.00
Corindus Vascular Robotics (CVRS) United States $0.581B 0.00
OrthoPediatrics (KIDS) United States $0.541B 0.00
Si-Bone (SIBN) United States $0.483B 0.00
GenMark Diagnostics (GNMK) United States $0.361B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.354B 18.99
RTI Surgical (RTIX) United States $0.312B 38.36
Accuray (ARAY) United States $0.309B 0.00
TransEnterix (TRXC) United States $0.304B 0.00
Semler Scientific (SMLR) United States $0.289B 57.37
SeaSpine Holdings (SPNE) United States $0.245B 0.00
Neuronetics (STIM) United States $0.235B 0.00
ConforMIS (CFMS) United States $0.231B 0.00
Alphatec Holdings (ATEC) United States $0.208B 0.00
IRadimed (IRMD) United States $0.203B 38.64
CRH Medical (CRHM) Canada $0.201B 69.75
Sientra (SIEN) United States $0.180B 0.00
Stereotaxis (STXS) United States $0.172B 0.00
Second Sight Medical Products (EYES) United States $0.100B 0.00
Ekso Bionics Holdings (EKSO) United States $0.093B 0.00
Sensus Healthcare (SRTS) United States $0.088B 0.00
Vermillion (VRML) United States $0.086B 0.00
EDAP TMS S.A (EDAP) France $0.078B 0.00
Covalon Technologies (CVALF) Canada $0.070B 0.00
T2 Biosystems (TTOO) United States $0.069B 0.00
Apollo Endosurgery (APEN) United States $0.066B 0.00
Spectral Diagnostics (EDTXF) Canada $0.066B 0.00
Helius Medical Technologies (HSDT) United States $0.053B 0.00